Engineered Phage Endolysin Eliminates Gardnerella Biofilm without Damaging Beneficial Bacteria in Bacterial Vaginosis Ex Vivo
暂无分享,去创建一个
M. Vaneechoutte | L. Tišáková | V. Oberbauer | A. Swidsinski | S. Swidsinski | Abbas J. Muhammad | L. Van Simaey | A. Guschin | C. Landlinger | L. Corsini | G. Resch | T. Schwebs | A. Latka | Mario Vaneechoutte
[1] Tatum D. Mortimer,et al. Lateral Gene Transfer Shapes Diversity of Gardnerella spp. , 2020, Frontiers in Cellular and Infection Microbiology.
[2] N. Gilbert,et al. Gardnerella vaginalis as a Cause of Bacterial Vaginosis: Appraisal of the Evidence From in vivo Models , 2020, Frontiers in Cellular and Infection Microbiology.
[3] D. Kwon,et al. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis , 2020, PLoS pathogens.
[4] E. Elinav,et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis , 2019, Nature Medicine.
[5] C. Consolandi,et al. Diversity of vaginal microbiome and metabolome during genital infections , 2019, Scientific Reports.
[6] Janet E. Hill,et al. Resolution and Cooccurrence Patterns of Gardnerella leopoldii, G. swidsinskii, G. piotii, and G. vaginalis within the Vaginal Microbiome , 2019, Infection and Immunity.
[7] Christopher M. Taylor,et al. An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis. , 2019, The Journal of infectious diseases.
[8] M. Unemo,et al. Quantitation of all Four Gardnerella vaginalis Clades Detects Abnormal Vaginal Microbiota Characteristic of Bacterial Vaginosis More Accurately than Putative G. vaginalis Sialidase A Gene Count , 2019, Molecular Diagnosis & Therapy.
[9] Daniela Machado,et al. Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial Vaginosis biofilms: the impact of other vaginal pathogens living as neighbors , 2019, The ISME Journal.
[10] M. Vaneechoutte,et al. Emended description of Gardnerella vaginalis and description of Gardnerella leopoldii sp. nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp. nov., with delineation of 13 genomic species within the genus Gardnerella. , 2019, International journal of systematic and evolutionary microbiology.
[11] P. Humaidan,et al. Reproductive outcome of patients undergoing in vitro fertilisation treatment and diagnosed with bacterial vaginosis or abnormal vaginal microbiota: a systematic PRISMA review and meta‐analysis , 2019, BJOG : an international journal of obstetrics and gynaecology.
[12] V. Yotova,et al. Vaginal microbiome in early pregnancy and subsequent risk of spontaneous preterm birth: a case–control study , 2018, BJOG : an international journal of obstetrics and gynaecology.
[13] J. Sobel,et al. Vulvovaginal candidiasis: histologic lesions are primarily polymicrobial and invasive and do not contain biofilms , 2019, American journal of obstetrics and gynecology.
[14] K. Jefferson,et al. Innate immune components affect growth and virulence traits of bacterial-vaginosis-associated and non-bacterial-vaginosis-associated Gardnerella vaginalis strains similarly. , 2018, Pathogens and disease.
[15] V. Fischetti. Development of Phage Lysins as Novel Therapeutics: A Historical Perspective , 2018, Viruses.
[16] M. Vaneechoutte,et al. The human vaginal microbial community. , 2017, Research in microbiology.
[17] S. Hillier,et al. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. , 2017, Anaerobe.
[18] Suzanna C Francis,et al. Sexually transmitted infections: challenges ahead. , 2017, The Lancet. Infectious diseases.
[19] M. Vaneechoutte,et al. Lactobacillus iners: Friend or Foe? , 2017, Trends in microbiology.
[20] V. Loening-Baucke,et al. Evaluation of Polymicrobial Involvement Using Fluorescence In Situ Hybridization (FISH) in Clinical Practice , 2017 .
[21] M. Zilliox,et al. Genomes of Gardnerella Strains Reveal an Abundance of Prophages within the Bladder Microbiome , 2016, PloS one.
[22] E. Diamandis,et al. Putative functions of tissue kallikrein-related peptidases in vaginal fluid , 2016, Nature Reviews Urology.
[23] J. Sobel,et al. Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation. , 2016, The Journal of infectious diseases.
[24] K. Murphy,et al. The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes. , 2016, The Journal of infectious diseases.
[25] M. Falagas,et al. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. , 2016, International journal of antimicrobial agents.
[26] B. Hollingsworth,et al. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections , 2016, Military Medical Research.
[27] J. Sobel,et al. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. , 2016, Diagnostic microbiology and infectious disease.
[28] N. Cerca,et al. Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis. , 2015, The Journal of infectious diseases.
[29] Chad W. Euler,et al. Using a Novel Lysin To Help Control Clostridium difficile Infections , 2015, Antimicrobial Agents and Chemotherapy.
[30] K. Jefferson,et al. Using an in-vitro biofilm model to assess the virulence potential of Bacterial Vaginosis or non-Bacterial Vaginosis Gardnerella vaginalis isolates , 2015, Scientific Reports.
[31] V. Loening-Baucke,et al. Polymicrobial Gardnerella biofilm resists repeated intravaginal antiseptic treatment in a subset of women with bacterial vaginosis: a preliminary report , 2015, Archives of Gynecology and Obstetrics.
[32] J. Castro,et al. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model. , 2014, The Journal of infectious diseases.
[33] J. Schwebke,et al. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. , 2014, The Journal of infectious diseases.
[34] V. Loening-Baucke,et al. Infection through structured polymicrobial Gardnerella biofilms (StPM-GB). , 2014, Histology and histopathology.
[35] M. Wittekind,et al. Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine Bacteremia , 2013, The Journal of infectious diseases.
[36] C. Kenyon,et al. The global epidemiology of bacterial vaginosis: a systematic review. , 2013, American journal of obstetrics and gynecology.
[37] P. De Sutter,et al. Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. , 2013, Human reproduction.
[38] K. Jefferson,et al. Interactions between Lactobacillus crispatus and Bacterial Vaginosis (BV)-Associated Bacterial Species in Initial Attachment and Biofilm Formation , 2013, International journal of molecular sciences.
[39] Franklin L. Nobrega,et al. Molecular Aspects and Comparative Genomics of Bacteriophage Endolysins , 2013, Journal of Virology.
[40] M. Loessner,et al. Bacteriophage endolysins as novel antimicrobials. , 2012, Future microbiology.
[41] W. Gregory,et al. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A7 2007 , 2012 .
[42] J. Klumpp,et al. Endolysins as antimicrobials. , 2012, Advances in virus research.
[43] A. Viale,et al. Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis , 2011, Infection and Immunity.
[44] M. Loessner,et al. Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity , 2011, Microbial biotechnology.
[45] M. Vaneechoutte,et al. Gardnerella Biofilm Involves Females and Males and Is Transmitted Sexually , 2010, Gynecologic and Obstetric Investigation.
[46] V. Fischetti,et al. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. , 2010, International journal of medical microbiology : IJMM.
[47] J. Mania-Pramanik,et al. Bacterial vaginosis: a cause of infertility? , 2009, International journal of STD & AIDS.
[48] H. Lochs,et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. , 2008, American journal of obstetrics and gynecology.
[49] H. Leitich,et al. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. , 2007, Best practice & research. Clinical obstetrics & gynaecology.
[50] H. Lochs,et al. Adherent Biofilms in Bacterial Vaginosis , 2005, Obstetrics and gynecology.
[51] A. Onderdonk,et al. Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. , 1997, The Journal of infectious diseases.
[52] S. Hillier,et al. Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora , 1992, Journal of clinical microbiology.
[53] R. Amann,et al. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations , 1990, Applied and environmental microbiology.
[54] J. Costerton,et al. Gardnerella vaginalis has a gram-positive cell-wall ultrastructure and lacks classical cell-wall lipopolysaccharide. , 1989, Journal of medical microbiology.
[55] Dr. Werner Mendling. Vulvovaginal Candidosis , 1988, Springer Berlin Heidelberg.
[56] K. Holmes,et al. Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .
[57] K.,et al. Amine content of vaginal fluid from untreated and treated patients with nonspecific vaginitis. , 1979, The Journal of clinical investigation.